Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cecile Holweg"'
Autor:
Evan Tan, Rachel Varughese, Ruth Semprini, Barney Montgomery, Cecile Holweg, Julie Olsson, Rachel Caswell-Smith, James Fingleton, Mark Weatherall, Richard Beasley, Irene Braithwaite
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-9 (2018)
Abstract Background Periostin has been shown to be a marker of Type 2 airway inflammation, associated with airway eosinophilia. It has a potential role in identifying asthmatics who may be responsive to treatment with monoclonal antibody therapy dire
Externí odkaz:
https://doaj.org/article/5025085231a14a94a80a5369c5ef0388
Autor:
Kasia Owczarczyk, Matthew D. Cascino, Cecile Holweg, Gaik W. Tew, Ward Ortmann, Timothy Behrens, Thomas Schindler, Carol A. Langford, E. William St. Clair, Peter A. Merkel, Robert Spiera, Philip Seo, Cees G.M. Kallenberg, Ulrich Specks, Noha Lim, John Stone, Paul Brunetta, Marco Prunotto, the RAVE-ITN Research Group
Publikováno v:
JCI Insight, Vol 5, Iss 18 (2020)
BACKGROUND Baseline expression of FCRL5, a marker of naive and memory B cells, was shown to predict response to rituximab (RTX) in rheumatoid arthritis. This study investigated baseline expression of FCRL5 as a potential biomarker of clinical respons
Externí odkaz:
https://doaj.org/article/b7bd1818f0e642e5849a9f696ba49b07
Autor:
Rachel Varughese, Ruth Semprini, Claire Munro, James Fingleton, Cecile Holweg, Mark Weatherall, Richard Beasley, Irene Braithwaite
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-10 (2018)
Abstract Background In asthma, serum periostin may potentially be used as a biomarker in the management of patients with Type-2 eosinophilic airway inflammation. However, serum periostin may be influenced by factors other than Type 2 inflammation, po
Externí odkaz:
https://doaj.org/article/4088611a2aa84514826a528ef70c2a86
Autor:
Nicole Chase, Benjamin Trzaskoma, Cecile Holweg, John Steinke, Lauren Millette, Thomas Casale
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB13
Autor:
Andrew Wilson, Sean Virani, Cecile Holweg, Jan Kielstein, Stefanie Bode-Boger, Hannah Valantine, John P Cooke, William F Fearon
Publikováno v:
Circulation. 116
Cardiac allograft vasculopathy (TAV) is a diffuse and progressive form of coronary artery disease occurring after heart transplantation (HT) characterized by endothelial dysfunction (ED) and negative arterial remodeling. However, TAV risk factors are